Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
about
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseStriatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicityTherapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of diseaseIs Huntington's disease a tauopathy?Faulty splicing and cytoskeleton abnormalities in Huntington's disease.Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease.Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.Mutant huntingtin alters Tau phosphorylation and subcellular distribution.Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
P2860
Q27011417-7A021315-9605-480F-B44D-1E72F4AAB264Q28239309-4736AAFD-7618-470F-A8DA-CEAEC0F7B3E6Q34233293-36D818C8-86B4-4B4F-849F-95E5E6989171Q37921617-EF5F8EED-A9F7-45EA-9992-1E840402B5D0Q37930190-D2A868BF-0485-46B1-B613-54FB1CBE646DQ37996350-F2B4780C-E6E9-4D5A-87FF-21FF8D081994Q38771048-6A618710-672E-4F93-8566-BF0947972945Q38928751-EB52455E-4D46-4F24-A2E2-00EB8791032BQ38928777-4232A26C-D9A6-4C99-A464-56B64425A87BQ38957994-AC8B63AE-849D-4E37-A8C2-AB255307ED05Q43848665-B7863639-5A36-4AC1-A277-08F6206C4C07Q45288661-62E008A2-F58B-4601-A636-3BED122C68ADQ45295696-A632E45E-45D3-4B5A-8B13-8E48630A4594Q45301226-D967F329-98F8-4471-A4ED-8C1DDD012324Q45303900-CA1A4B28-E2E1-43AC-A02B-1449482ECE47Q45306525-6926B331-5529-4778-BBF9-02E330D729BEQ50206457-E4FA4CCB-6185-45B1-8D1F-39B8E065BB8B
P2860
Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@en
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@nl
type
label
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@en
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@nl
prefLabel
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@en
Reduced calcineurin protein le ...... sease: role in excitotoxicity.
@nl
P50
P1476
Reduced calcineurin protein le ...... isease: role in excitotoxicity
@en
P2093
Ana Saavedra
Juan M García-Martínez
P304
P356
10.1016/J.NBD.2009.08.012
P577
2009-09-04T00:00:00Z